UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients

European journal of clinical pharmacology, 2023-11, Vol.79 (11), p.1537-1547

2023

Volltextzugriff (PDF)

The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions

Platelets (Edinburgh), 2022-02, Vol.33 (2), p.273-277

2022

Volltextzugriff (PDF)

The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions

Journal of thrombosis and haemostasis, 2017-04, Vol.15 (4), p.618-623

2017

Volltextzugriff (PDF)

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

Thrombosis research, 2020-12, Vol.196, p.1-3

2020

Volltextzugriff (PDF)

Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) study

Thrombosis research, 2022-10, Vol.218, p.177-185

2022

Volltextzugriff (PDF)

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

Journal of thrombosis and haemostasis, 2010-03, Vol.8 (3), p.482-488

2010

Volltextzugriff (PDF)

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline

Platelets (Edinburgh), 2021-05, Vol.32 (4), p.516-523

2021

Volltextzugriff (PDF)

High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2140-2148

2010

Volltextzugriff (PDF)

Low-density lipoprotein and its effect on human blood platelets

Cellular and molecular life sciences : CMLS, 2003-05, Vol.60 (5), p.961-971

2003

Volltextzugriff (PDF)

Variability in on-treatment platelet reactivity explained by CYP2C192 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

Heart (British Cardiac Society), 2011-08, Vol.97 (15), p.1239-1244

2011

Volltextzugriff (PDF)

The hypercoagulable profile of patients with stent thrombosis

Heart (British Cardiac Society), 2015-07, Vol.101 (14), p.1126-1132

2015

Volltextzugriff (PDF)

A head‐to‐head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

Journal of thrombosis and haemostasis, 2006-11, Vol.4 (11), p.2516-2518

2006

Volltextzugriff (PDF)

Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C192 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

Journal of thrombosis and haemostasis, 2011-10, Vol.9 (10), p.1892-1901

2011

Volltextzugriff (PDF)

Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients

Circulation (New York, N.Y.), 2004-01, Vol.109 (1), p.23-25

2004

Volltextzugriff (PDF)

The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence

Platelets (Edinburgh), 2008-11, Vol.19 (7), p.479-488

2008

Volltextzugriff (PDF)

Effect of gender difference on platelet reactivity

Netherlands heart journal, 2011-11, Vol.19 (11), p.451-457

2011

Volltextzugriff (PDF)

A case–control study on platelet reactivity in patients with coronary stent thrombosis

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.909-916

2011

Volltextzugriff (PDF)

The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor

Thrombosis and haemostasis, 2010-02, Vol.103 (2), p.379

2010

Volltextzugriff (PDF)

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1929-1932

2009

Volltextzugriff (PDF)

Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2326-2328

2010

Volltextzugriff (PDF)

Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.884-886

2007

Volltextzugriff (PDF)

Clopidogrel resistance: fact and fiction

Future cardiology, 2006-03, Vol.2 (2), p.215-228

2006

Volltextzugriff (PDF)

High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial

Journal of cardiovascular surgery, 2013-06, Vol.54 (3), p.337

2013

Volltextzugriff (PDF)

The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.881-883

2007

Volltextzugriff (PDF)

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

Journal of thrombosis and haemostasis, 2008-06, Vol.6 (6), p.1040-1042

2008

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(125)
Humans
(122)
Female
(63)
Cardiovascular System & Cardiology
(61)
Male
(60)
Hematology
(55)
Peripheral Vascular Disease
(49)
Middle Aged
(46)
Aged
(45)
Biological And Medical Sciences
(44)
Medical Sciences
(35)
Animals
(26)
Adult
(25)
Clopidogrel
(20)
Cardiac & Cardiovascular Systems
(19)
Mice
(19)
Ticlopidine - Analogs & Derivatives
(19)
Fundamental And Applied Biological Sciences. Psychology
(15)
Prospective Studies
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients

The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions

The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) study

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline

High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events

Low-density lipoprotein and its effect on human blood platelets

Variability in on-treatment platelet reactivity explained by CYP2C192 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

The hypercoagulable profile of patients with stent thrombosis

A head‐to‐head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C192 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention

Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients

The use of the VerifyNow system to monitor antiplatelet therapy: A review of the current evidence

Effect of gender difference on platelet reactivity

A case–control study on platelet reactivity in patients with coronary stent thrombosis

The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests

Do not adjust the platelet count in light transmittance aggregometry when predicting thrombotic events after percutaneous coronary intervention

Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?

Clopidogrel resistance: fact and fiction

High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial

The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

Suchergebnisse filtern